CAM
NTUS

Cresset Asset Management’s Natus Medical Inc NTUS Stock Holding History

Cresset Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-75
Closed -$3K – 2146
2018
Q4 		$3K Buy
+75
New +$2.44K ﹤0.01% 1242

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cresset Asset Management's NTUS Position: Q1 2019 in Review

Cresset Asset Management sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 75 shares — an estimated $3K sold.

Cresset Asset Management first reported a position in NTUS in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Cresset Asset Management reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Cresset Asset Management sold 75 Natus Medical Inc shares in Q1 2019, an estimated $3K.
  • Cresset Asset Management first reported a position in Natus Medical Inc in Q4 2018 and held it in 1 quarter.
  • Cresset Asset Management's Natus Medical Inc position peaked at $3K in Q4 2018.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Cresset Asset Management's 13F filing for Q1 2019, filed 15 May 2019.